{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:11:18Z","timestamp":1767913878379,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To investigate the prognostic significance of station 4R lymph node (LN) dissection in patients who underwent operations for right primary non-small cell lung cancer (NSCLC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective study involving patients with right primary NSCLC who received lobotomy or pneumonectomy with mediastinal LN dissection between January 2011 and December 2017. Propensity score matching was performed. Disease-free survival (DFS) and overall survival (OS) were compared between patients with and without station 4R dissection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our study included 2070 patients, with 207 patients having no station 4R dissection (S4RD\u2212 group) and 1863 patients having station 4R dissection (S4RD+ group). The 4R LN metastasis rate was 13.4% (142\/1748), higher than that for other mediastinal LN metastases. Compared with the S4RD\u2212 group, the S4RD+ group had higher 5-year DFS (48.1% vs. 39.1%, <jats:italic>P<\/jats:italic>\u2009=\u20090.009) and OS (54.4% vs. 42.8%, <jats:italic>P<\/jats:italic>\u2009=\u20090.025). Station 4R dissection was an independent risk factor for DFS (odds ratio, OR, 1.28, 95% confidence interval, CI, 1.08\u20131.64, <jats:italic>P<\/jats:italic>\u2009=\u20090.007) and OS (OR 1.31, 95% CI 1.04\u20131.63, <jats:italic>P<\/jats:italic>\u2009=\u20090.018). Patients with adjuvant chemotherapy had a better prognosis after station 4R dissection than those without adjuvant chemotherapy (57.4% vs. 52.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.006). The 5-year OS in the station 4R metastasis group was lower than that in the station 4R non-metastasis group (26.9% vs. 44.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.006) among N2 patients. The 5-year OS of the single-station 4R metastasis group was lower than that of the single-station 7 metastasis group (15.7% vs. 51.6%, <jats:italic>P<\/jats:italic>\u2009=\u20090.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Station 4R metastasis was the highest among all the mediastinal station metastases in right primary NSCLC patients. Station 4R dissection can improve the prognosis and should be recommended as a routine procedure for these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02689-w","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T06:02:42Z","timestamp":1656655362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Di","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingnan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2689_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2689_CR2","volume-title":"Non small cell lung cancer","author":"SB Clark","year":"2021","unstructured":"Clark SB, Alsubait S. Non small cell lung cancer. Treasure Island: StatPearls; 2021."},{"key":"2689_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","volume":"5","author":"C Zappa","year":"2016","unstructured":"Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5:288\u2013300.","journal-title":"Transl Lung Cancer Res"},{"key":"2689_CR4","doi-asserted-by":"publisher","first-page":"137S","DOI":"10.1378\/chest.123.1_suppl.137S","volume":"123","author":"EM Toloza","year":"2003","unstructured":"Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003;123:137S\u201346S.","journal-title":"Chest"},{"issue":"11","key":"2689_CR5","first-page":"CD009519","volume":"2014","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roque IFM. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;2014(11):CD009519.","journal-title":"Cochrane Database Syst Rev"},{"key":"2689_CR6","volume-title":"NCCN clinical practice guidelines in oncology: non-small cell lung cancer (version 3.2020)","author":"National Comprehensive Cancer Network","year":"2020","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer (version 3.2020). 2020."},{"key":"2689_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s11748-012-0086-3","volume":"60","author":"J Deslauriers","year":"2012","unstructured":"Deslauriers J. Mediastinal lymph nodes: ignore? sample? dissect? The role of mediastinal node dissection in the surgical management of primary lung cancer. Gen Thorac Cardiovasc Surg. 2012;60:724\u201334.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2689_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1245\/s10434-020-08786-y","volume":"28","author":"C Liu","year":"2021","unstructured":"Liu C, Wei S, Guo C, Mei J, Pu Q, Liu L. Clinical significance of station 3A lymph node dissection in patients with right-side non-small-cell lung cancer: a retrospective propensity-matched analysis. Ann Surg Oncol. 2021;28:194\u2013202.","journal-title":"Ann Surg Oncol"},{"key":"2689_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.athoracsur.2018.02.054","volume":"106","author":"SR Turner","year":"2018","unstructured":"Turner SR, Seyednejad N, Nasir BS. Patterns of practice in mediastinal lymph node staging for non-small cell lung cancer in Canada. Ann Thorac Surg. 2018;106:428\u201334.","journal-title":"Ann Thorac Surg"},{"key":"2689_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/ejcts\/ezy479","volume":"56","author":"MZ Yang","year":"2019","unstructured":"Yang MZ, Hou X, Liang RB, Lai RC, Yang J, Li S, et al. The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3\u2009cm or less: data from 2292 cases. Eur J Cardiothorac Surg. 2019;56:159\u201366.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2689_CR11","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1245\/s10434-018-6394-9","volume":"25","author":"RB Liang","year":"2018","unstructured":"Liang RB, Yang J, Zeng TS, Long H, Fu JH, Zhang LJ, et al. Incidence and distribution of lobe-specific mediastinal lymph node metastasis in non-small cell lung cancer: data from 4511 resected cases. Ann Surg Oncol. 2018;25:3300\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2689_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/JTO.0b013e3181a0d82e","volume":"4","author":"VW Rusch","year":"2009","unstructured":"Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4:568\u201377.","journal-title":"J Thorac Oncol"},{"key":"2689_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"2689_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"2689_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejcts.2008.03.060","volume":"34","author":"W Zhong","year":"2008","unstructured":"Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Eur J Cardiothorac Surg. 2008;34:187\u201395.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2689_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.athoracsur.2007.04.032","volume":"84","author":"BA Whitson","year":"2007","unstructured":"Whitson BA, Groth SS, Maddaus MA. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg. 2007;84:1059\u201365.","journal-title":"Ann Thorac Surg"},{"key":"2689_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jtcvs.2010.11.008","volume":"141","author":"GE Darling","year":"2011","unstructured":"Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662\u201370.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2689_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1378\/chest.10-0859","volume":"139","author":"GE Darling","year":"2011","unstructured":"Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Chest. 2011;139:1124\u20139.","journal-title":"Chest"},{"key":"2689_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ejcts.2006.08.008","volume":"30","author":"D Lardinois","year":"2006","unstructured":"Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30:787\u201392.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2689_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.thorsurg.2006.12.011","volume":"17","author":"M Riquet","year":"2007","unstructured":"Riquet M. Bronchial arteries and lymphatics of the lung. Thorac Surg Clin. 2007;17:619\u201338 viii.","journal-title":"Thorac Surg Clin"},{"key":"2689_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1510\/icvts.2010.236349","volume":"11","author":"M Riquet","year":"2010","unstructured":"Riquet M, Arame A, Foucault C, Le Pimpec BF. Prognostic classifications of lymph node involvement in lung cancer and current International Association for the Study of Lung Cancer descriptive classification in zones. Interact Cardiovasc Thorac Surg. 2010;11:260\u20134.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2689_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/icvts\/ivt265","volume":"17","author":"H Zheng","year":"2013","unstructured":"Zheng H, Gao W, Fei K, Xie HK, Jiang GN, Ding JA, et al. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers. Interact Cardiovasc Thorac Surg. 2013;17:447\u201354.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2689_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/JTO.0b013e31820b8891","volume":"6","author":"Y Sakao","year":"2011","unstructured":"Sakao Y, Okumura S, Mingyon M, Uehara H, Ishikawa Y, Nakagawa K. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe. J Thorac Oncol. 2011;6:494\u20139.","journal-title":"J Thorac Oncol"},{"key":"2689_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0300-2896(01)75129-0","volume":"37","author":"GCCB-S","year":"2001","unstructured":"GCCB-S. Intraoperative lymph node staging in bronchogenic carcinoma surgery. Consensus report. Arch Bronconeumol. 2001;37:495\u2013503.","journal-title":"Arch Bronconeumol"},{"key":"2689_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.29271\/jcpsp.2020.02.172","volume":"30","author":"M Kuzucuoglu","year":"2020","unstructured":"Kuzucuoglu M, Gokyer A, Kula O, Yekdes AC, Sunal BS, Karamustafaoglu YA, et al. Relationship between the size and location of the mass and hilar and mediastinal lymph node metastasis in early and locally advanced non-small cell lung cancer. J Coll Physicians Surg Pak. 2020;30:172\u20136.","journal-title":"J Coll Physicians Surg Pak"},{"key":"2689_CR26","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1016\/j.cllc.2018.12.007","volume":"20","author":"L Wang","year":"2019","unstructured":"Wang L, Zhan C, Gu J, Xi J, Lin Z, Xue L, et al. Role of skip mediastinal lymph node metastasis for patients with resectable non-small-cell lung cancer: a propensity score matching analysis. Clin Lung Cancer. 2019;20:e346\u2013e55.","journal-title":"Clin Lung Cancer"},{"key":"2689_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12957-017-1098-3","volume":"15","author":"YK Zhang","year":"2017","unstructured":"Zhang YK, Chai ZD, Tan LL, Wang ZY, Chen ZJ, Le HB, et al. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer. World J Surg Oncol. 2017;15:64.","journal-title":"World J Surg Oncol"},{"key":"2689_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12957-020-01946-0","volume":"18","author":"B Jia","year":"2020","unstructured":"Jia B, Chen B, Long H, Rong T, Su X. Tumor volume is more reliable to predict nodal metastasis in non-small cell lung cancer of 3.0\u2009cm or less in the greatest tumor diameter. World J Surg Oncol. 2020;18:168.","journal-title":"World J Surg Oncol"},{"key":"2689_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-7819-12-42","volume":"12","author":"B Ye","year":"2014","unstructured":"Ye B, Cheng M, Ge XX, Geng JF, Li W, Feng J, et al. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas. World J Surg Oncol. 2014;12:42.","journal-title":"World J Surg Oncol"},{"key":"2689_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4149\/neo_2013_027","volume":"60","author":"HB Liu","year":"2013","unstructured":"Liu HB, Gu XL, Ma XQ, Lv TF, Wu Y, Xiao YY, et al. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer. Neoplasma. 2013;60:203\u20138.","journal-title":"Neoplasma"},{"key":"2689_CR31","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1111\/crj.12786","volume":"12","author":"XL Gao","year":"2018","unstructured":"Gao XL, Wang SS, Cao DB, Liu W. The role of plasma D-dimer levels for predicting lymph node and mediastinal lymph node involvement in non-small cell lung cancer. Clin Respir J. 2018;12:2151\u20136.","journal-title":"Clin Respir J"},{"key":"2689_CR32","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.athoracsur.2012.05.034","volume":"94","author":"RJ Cerfolio","year":"2012","unstructured":"Cerfolio RJ, Bryant AS, Minnich DJ. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer. Ann Thorac Surg. 2012;94:902\u20136.","journal-title":"Ann Thorac Surg"},{"key":"2689_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/JTO.0b013e3181e29ace","volume":"5","author":"AF Verhagen","year":"2010","unstructured":"Verhagen AF, Bulten J, Shirango H, Thunnissen FB, van der Drift MA, van der Bruggen W, et al. The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer. J Thorac Oncol. 2010;5:1201\u20135.","journal-title":"J Thorac Oncol"},{"key":"2689_CR34","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1200\/JCO.2018.78.7101","volume":"36","author":"YN Wang","year":"2018","unstructured":"Wang YN, Yao S, Wang CL, Li MS, Sun LN, Yan QN, et al. Clinical significance of 4L lymph node dissection in left lung cancer. J Clin Oncol. 2018;36:2935\u201342.","journal-title":"J Clin Oncol"},{"key":"2689_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12957-020-02027-y","volume":"18","author":"W Zhai","year":"2020","unstructured":"Zhai W, Duan F, Zheng Y, Yan Q, Dai S, Chen T, et al. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study. World J Surg Oncol. 2020;18:258.","journal-title":"World J Surg Oncol"},{"key":"2689_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12957-020-02090-5","volume":"18","author":"LL Wu","year":"2020","unstructured":"Wu LL, Lai JJ, Liu X, Huang YY, Lin P, Long H, et al. Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis. World J Surg Oncol. 2020;18:322.","journal-title":"World J Surg Oncol"},{"key":"2689_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12957-016-1048-5","volume":"14","author":"M Tamura","year":"2016","unstructured":"Tamura M, Matsumoto I, Saito D, Yoshida S, Takata M, Takemura H. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer. World J Surg Oncol. 2016;14:295.","journal-title":"World J Surg Oncol"},{"key":"2689_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12957-016-1038-7","volume":"14","author":"W Zhang","year":"2016","unstructured":"Zhang W, Wei Y, Jiang H, Xu J, Yu D. Thoracotomy is better than thoracoscopic lobectomy in the lymph node dissection of lung cancer: a systematic review and meta-analysis. World J Surg Oncol. 2016;14:290.","journal-title":"World J Surg Oncol"},{"key":"2689_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12957-021-02364-6","volume":"19","author":"Y Chai","year":"2021","unstructured":"Chai Y, Ma Y, Feng W, Lu H, Jin L. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation. World J Surg Oncol. 2021;19:258.","journal-title":"World J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02689-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T06:03:53Z","timestamp":1656655433000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02689-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2689"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02689-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the hospital ethics committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}